$ 1,250.0

Quantity: 20 MG

Available on backorder


Product name: RADA16-I

Catalog#: 1502001


Sequence: Ac-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-NH2

Modifications: N-terminal acetylation, C-terminal amide,

M.W: 1712.81

M.F.: C66H113N29O25

Purity: 85%

Counter ion: Trifluoacetate

Format: Lyophilized powder

Description: RADA16-I is able self-assemble into well-ordered nanoibers and further form scaffolds. The scaffold has a three-dimensional structure similar to naturally occuring extracellular matrix (ECM), and has been reported to support cell attachment, proliferation, and differentiation, and act as an effective hemostatic medicine. RADA16 exhibited three distinct assembly patterns depending on its concentration, and one of these assemblies, formed with 0.01% (w/v) RADA16, was capable of inducing differentiation of human myelocytic leukemia HL-60 cells into monocytes/macrophages.


Usage: For Scientific Research Use Only, Not for Human Use.